These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10711552)

  • 21. Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure.
    Bourgain C; Devroey P; Van Waesberghe L; Smitz J; Van Steirteghem AC
    Hum Reprod; 1990 Jul; 5(5):537-43. PubMed ID: 2394784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.
    Zarutskie PW; Phillips JA
    Fertil Steril; 2009 Jul; 92(1):163-9. PubMed ID: 19362303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endometrial morphology and ultrasound vascular findings. A randomized trial after intramuscular and vaginal progesterone supplementation in IVF.
    Ragni G; Piloni S; Rossi P; Carinelli S; De Lauretis L; Vegetti W; Crosignani PG
    Gynecol Obstet Invest; 1999; 47(3):151-6. PubMed ID: 10087407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Crinone vaginal progesterone gel for luteal support in in vitro fertilization cycles.
    Chantilis SJ; Zeitoun KM; Patel SI; Johns DA; Madziar VA; McIntire DD
    Fertil Steril; 1999 Nov; 72(5):823-9. PubMed ID: 10560985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of natural progesterone administered in the form of a vaginal tablet.
    Levy T; Gurevitch S; Bar-Hava I; Ashkenazi J; Magazanik A; Homburg R; Orvieto R; Ben-Rafael Z
    Hum Reprod; 1999 Mar; 14(3):606-10. PubMed ID: 10221683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Danazol concentrations in ovary, uterus, and serum and their effect on the hypothalamic-pituitary-ovarian axis during vaginal administration of a danazol suppository.
    Mizutani T; Nishiyama S; Amakawa I; Watanabe A; Nakamuro K; Terada N
    Fertil Steril; 1995 Jun; 63(6):1184-9. PubMed ID: 7750586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and tolerability of a novel progesterone intravaginal ring in sheep.
    Weiss H; Martell B; Constantine GD; Davis SM; Vidal JD; Mayer PR; Doorbar M; Friend DR
    Drug Deliv Transl Res; 2019 Oct; 9(5):1008-1016. PubMed ID: 31066007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study.
    Lewin A; Pisov G; Turgeman R; Fatum M; Shufaro Y; Simon A; Laufer N; Revel A; Reubinoff B; Safran A
    Gynecol Endocrinol; 2002 Apr; 16(2):131-6. PubMed ID: 12012623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients' administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support.
    Beltsos AN; Sanchez MD; Doody KJ; Bush MR; Domar AD; Collins MG
    Reprod Health; 2014 Nov; 11():78. PubMed ID: 25385669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular route of progesterone administration increases pregnancy rates during non-downregulated frozen embryo transfer cycles.
    Haddad G; Saguan DA; Maxwell R; Thomas MA
    J Assist Reprod Genet; 2007 Oct; 24(10):467-70. PubMed ID: 17721816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral progesterone (P) levels and endometrial response to various dosages of vaginally administered P in estrogen-primed women.
    Pasquale SA; Foldesy RG; Levine JP; Bachmann GA; Blackwell RE
    Fertil Steril; 1997 Nov; 68(5):810-5. PubMed ID: 9389807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaginal rings for menopausal symptom relief.
    Ballagh SA
    Drugs Aging; 2004; 21(12):757-66. PubMed ID: 15382956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized study comparing Crinone 8% and intramuscular progesterone supplementation in in vitro fertilization-embryo transfer cycles.
    Propst AM; Hill JA; Ginsburg ES; Hurwitz S; Politch J; Yanushpolsky EH
    Fertil Steril; 2001 Dec; 76(6):1144-9. PubMed ID: 11730742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphometric, immunohistological and three-dimensional evaluation of the endometrium of menopausal women treated by oestrogen and Crinone, a new slow-release vaginal progesterone.
    Casanas-Roux F; Nisolle M; Marbaix E; Smets M; Bassil S; Donnez J
    Hum Reprod; 1996 Feb; 11(2):357-63. PubMed ID: 8671224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transvaginal administration of progesterone.
    Fanchin R; De Ziegler D; Bergeron C; Righini C; Torrisi C; Frydman R
    Obstet Gynecol; 1997 Sep; 90(3):396-401. PubMed ID: 9277651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Variation in plasma progesterone induced by the vaginal administration of Utrogestan].
    Erny R; Simoncini C; Chastellière N; de Lignères B
    J Gynecol Obstet Biol Reprod (Paris); 1989; 18(2):229-34. PubMed ID: 2723354
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaginal versus oral E(2) administration: effects on endometrial thickness, uterine perfusion, and contractility.
    Fanchin R; Righini C; Schönauer LM; Olivennes F; Cunha Filho JS; Frydman R
    Fertil Steril; 2001 Nov; 76(5):994-8. PubMed ID: 11704123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.